Showing codes C9097 (Inj, faricimab-svoa, 0.1 mg) — C9154 (Injection, buprenorphine extended-release (brixadi), 1 mg)

C9097 - Inj, faricimab-svoa, 0.1 mg
Long description: Inj, faricimab-svoa, 0.1 mg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9098 - Ciltacabtagene car pos t
Long description: Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9101 - Inj, oliceridine 0.1 mg
Long description: Injection, oliceridine, 0.1 mg
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9113 - Inj pantoprazole sodium, via
Long description: Injection, pantoprazole sodium, per vial
Code added date: 20020101.
Code effective date: 20240701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9121 - Injection, argatroban
Long description: Injection, argatroban, per 5 mg
Code added date: 20030101.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9122 - Mometasone furoate (sinuva)
Long description: Mometasone furoate sinus implant, 10 micrograms (sinuva)
Code added date: 20200701.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9130 - Injection, ivig bivigam
Long description: Injection, immune globulin (bivigam), 500 mg
Code added date: 20130401.
Code effective date: 20140101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9131 - In ado-trastuzumab emtansine
Long description: Injection, ado-trastuzumab emtansine, 1 mg
Code added date: 20130701.
Code effective date: 20140101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9132 - Kcentra, per i.u.
Long description: Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
Code added date: 20131001.
Code effective date: 20210701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9133 - Factor ix recombinant
Long description: Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
Code added date: 20140101.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9134 - Factor xiii a-subunit recomb
Long description: Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9135 - Factor ix (alprolix)
Long description: Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
Code added date: 20141001.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9136 - Factor viii (eloctate)
Long description: Injection, factor viii, fc fusion protein, (recombinant), per i.u.
Code added date: 20150101.
Code effective date: 20150401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9137 - Adynovate factor viii recom
Long description: Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9138 - Nuwiq factor viii recomb
Long description: Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9139 - Idelvion, 1 i.u.
Long description: Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
Code added date: 20161001.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9140 - Afstyla factor viii recomb
Long description: Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
Code added date: 20170101.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9141 - Factor viii pegylated-aucl
Long description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
Code added date: 20190401.
Code effective date: 20190701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9142 - Inj, alymsys, 10 mg
Long description: Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Code added date: 20221001.
Code effective date: 20230101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9143 - Cocaine hcl nasal (numbrino)
Long description: Cocaine hydrochloride nasal solution (numbrino), 1 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9144 - Inj, bupivacaine (posimir)
Long description: Injection, bupivacaine (posimir), 1 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9145 - Inj, aponvie, 1 mg
Long description: Injection, aprepitant, (aponvie), 1 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9146 - Inj, elahere, 1 mg
Long description: Injection, mirvetuximab soravtansine-gynx, 1 mg
Code added date: 20230401.
Code effective date: 20230701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9147 - Inj, tremelimumab-actl, 1 mg
Long description: Injection, tremelimumab-actl, 1 mg
Code added date: 20230401.
Code effective date: 20230701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9148 - Inj, teclistamab-cqyv, 0.5mg
Long description: Injection, teclistamab-cqyv, 0.5 mg
Code added date: 20230401.
Code effective date: 20230701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9149 - Inj, teplizumab-mzwv, 5 mcg
Long description: Injection, teplizumab-mzwv, 5 mcg
Code added date: 20230401.
Code effective date: 20230701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9150 - Xe129 xenon, diagnostic
Long description: Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
Code added date: 20230701.
Code effective date: 20241001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9151 - Inj, pegcetacoplan 1 mg
Long description: Injection, pegcetacoplan, 1 mg
Code added date: 20230701.
Code effective date: 20231001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9152 - Inj, abilify asimtufii, 1 mg
Long description: Injection, aripiprazole, (abilify asimtufii), 1 mg
Code added date: 20231001.
Code effective date: 20240101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9153 - Inj, amisulpride, 1 mg
Long description: Injection, amisulpride, 1 mg
Code added date: 20231001.
Code effective date: 20240101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9154 - Inj buprenorph (brixadi) 1mg
Long description: Injection, buprenorphine extended-release (brixadi), 1 mg
Code added date: 20231001.
Code effective date: 20240101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF